Laney K Jones1, Stephanie Tilberry2, Christina Gregor3, Lauren H Yaeger4, Yirui Hu5, Amy C Sturm2, Terry L Seaton6,7, Thomas J Waltz8, Alanna K Rahm2, Anne Goldberg9, Ross C Brownson10,11, Samuel S Gidding2, Marc S Williams2, Michael R Gionfriddo3. 1. Genomic Medicine Institute, Geisinger, 100 N Academy Ave., Danville, PA, 17822, USA. Ljones14@geisinger.edu. 2. Genomic Medicine Institute, Geisinger, 100 N Academy Ave., Danville, PA, 17822, USA. 3. Center for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA, USA. 4. Bernard Becker Medical Library, Washington University in St. Louis, St. Louis, MO, USA. 5. Population Health Sciences, Geisinger, Danville, PA, USA. 6. University of Health Sciences and Pharmacy in St. Louis, St. Louis, MO, USA. 7. Population Health, Mercy Clinic-East Communities, St. Louis, MO, USA. 8. Eastern Michigan University, Ypsilanti, MI, USA. 9. Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, USA. 10. Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, St. Louis, MO, USA. 11. Department of Surgery (Division of Public Health Sciences) and Alvin J. Siteman Cancer Center, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Abstract
BACKGROUND: Numerous implementation strategies to improve utilization of statins in patients with hypercholesterolemia have been utilized, with varying degrees of success. The aim of this systematic review is to determine the state of evidence of implementation strategies on the uptake of statins. METHODS AND RESULTS: This systematic review identified and categorized implementation strategies, according to the Expert Recommendations for Implementing Change (ERIC) compilation, used in studies to improve statin use. We searched Ovid MEDLINE, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and Clinicaltrials.gov from inception to October 2018. All included studies were reported in English and had at least one strategy to promote statin uptake that could be categorized using the ERIC compilation. Data extraction was completed independently, in duplicate, and disagreements were resolved by consensus. We extracted LDL-C (concentration and target achievement), statin prescribing, and statin adherence (percentage and target achievement). A total of 258 strategies were used across 86 trials. The median number of strategies used was 3 (SD 2.2, range 1-13). Implementation strategy descriptions often did not include key defining characteristics: temporality was reported in 59%, dose in 52%, affected outcome in 9%, and justification in 6%. Thirty-one trials reported at least 1 of the 3 outcomes of interest: significantly reduced LDL-C (standardized mean difference [SMD] - 0.17, 95% CI - 0.27 to - 0.07, p = 0.0006; odds ratio [OR] 1.33, 95% CI 1.13 to 1.58, p = 0.0008), increased rates of statin prescribing (OR 2.21, 95% CI 1.60 to 3.06, p < 0.0001), and improved statin adherence (SMD 0.13, 95% CI 0.06 to 0.19; p = 0.0002; OR 1.30, 95% CI 1.04 to 1.63, p = 0.023). The number of implementation strategies used per study positively influenced the efficacy outcomes. CONCLUSION: Although studies demonstrated improved statin prescribing, statin adherence, and reduced LDL-C, no single strategy or group of strategies consistently improved outcomes. TRIAL REGISTRATION: PROSPERO CRD42018114952 .
BACKGROUND: Numerous implementation strategies to improve utilization of statins in patients with hypercholesterolemia have been utilized, with varying degrees of success. The aim of this systematic review is to determine the state of evidence of implementation strategies on the uptake of statins. METHODS AND RESULTS: This systematic review identified and categorized implementation strategies, according to the Expert Recommendations for Implementing Change (ERIC) compilation, used in studies to improve statin use. We searched Ovid MEDLINE, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and Clinicaltrials.gov from inception to October 2018. All included studies were reported in English and had at least one strategy to promote statin uptake that could be categorized using the ERIC compilation. Data extraction was completed independently, in duplicate, and disagreements were resolved by consensus. We extracted LDL-C (concentration and target achievement), statin prescribing, and statin adherence (percentage and target achievement). A total of 258 strategies were used across 86 trials. The median number of strategies used was 3 (SD 2.2, range 1-13). Implementation strategy descriptions often did not include key defining characteristics: temporality was reported in 59%, dose in 52%, affected outcome in 9%, and justification in 6%. Thirty-one trials reported at least 1 of the 3 outcomes of interest: significantly reduced LDL-C (standardized mean difference [SMD] - 0.17, 95% CI - 0.27 to - 0.07, p = 0.0006; odds ratio [OR] 1.33, 95% CI 1.13 to 1.58, p = 0.0008), increased rates of statin prescribing (OR 2.21, 95% CI 1.60 to 3.06, p < 0.0001), and improved statin adherence (SMD 0.13, 95% CI 0.06 to 0.19; p = 0.0002; OR 1.30, 95% CI 1.04 to 1.63, p = 0.023). The number of implementation strategies used per study positively influenced the efficacy outcomes. CONCLUSION: Although studies demonstrated improved statin prescribing, statin adherence, and reduced LDL-C, no single strategy or group of strategies consistently improved outcomes. TRIAL REGISTRATION: PROSPERO CRD42018114952 .
Authors: Rikki M Tanner; Monika M Safford; Keri L Monda; Benjamin Taylor; Ronan O'Beirne; Melanie Morris; Lisandro D Colantonio; Ricardo Dent; Paul Muntner; Robert S Rosenson Journal: Cardiovasc Drugs Ther Date: 2017-06 Impact factor: 3.727
Authors: A Zamora; F Fernández de Bobadilla; C Carrion; G Vázquez; G Paluzie; R Elosua; M Vilaseca; A Martín-Urda; A Rivera; N Plana; L Masana Journal: Atherosclerosis Date: 2013-10-18 Impact factor: 5.162
Authors: Sameer Bansilal; Jose Maria Castellano; Ester Garrido; Henry G Wei; Allison Freeman; Claire Spettell; Fernando Garcia-Alonso; Irene Lizano; Renee J G Arnold; Jay Rajda; Gregory Steinberg; Valentin Fuster Journal: J Am Coll Cardiol Date: 2016-08-23 Impact factor: 24.094
Authors: Angela Ju; Camilla S Hanson; Emily Banks; Rosemary Korda; Jonathan C Craig; Tim Usherwood; Peter MacDonald; Allison Tong Journal: Br J Gen Pract Date: 2018-06 Impact factor: 5.386
Authors: Fatima Rodriguez; David J Maron; Joshua W Knowles; Salim S Virani; Shoutzu Lin; Paul A Heidenreich Journal: JAMA Cardiol Date: 2019-03-01 Impact factor: 14.676
Authors: Laney K Jones; Amy C Sturm; Terry L Seaton; Christina Gregor; Samuel S Gidding; Marc S Williams; Alanna Kulchak Rahm Journal: PLoS One Date: 2020-12-23 Impact factor: 3.240
Authors: Laney K Jones; Marc S Williams; Ilene G Ladd; Dylan Cawley; Shuping Ge; Jing Hao; Dina Hassen; Yirui Hu; H Lester Kirchner; Maria Kobylinski; Michael G Lesko; Matthew C Nelson; Alanna K Rahm; David D Rolston; Katrina M Romagnoli; Tyler J Schubert; Timothy C Shuey; Amy C Sturm; Samuel S Gidding Journal: J Pers Med Date: 2022-04-09
Authors: Pariswi Tewari; Brian F Sweeney; Jacie L Lemos; Lauren Shapiro; Michael J Gardner; Arden M Morris; Laurence C Baker; Alex S Harris; Robin N Kamal Journal: JAMA Netw Open Date: 2022-09-01
Authors: Laney K Jones; Nicole Walters; Andrew Brangan; Catherine D Ahmed; Michael Gatusky; Gemme Campbell-Salome; Ilene G Ladd; Amanda Sheldon; Samuel S Gidding; Mary P McGowan; Alanna K Rahm; Amy C Sturm Journal: J Pers Med Date: 2021-06-21